ReviewActa paediatrica (Oslo, Norway : 1992)2026
Bleeding Disorders in Children With Genetic Diseases: A Narrative Review.
Review in Acta paediatrica (Oslo, Norway : 1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThe lack of data on bleeding risk assessment in children with genetic diseases is concerning given their increased care needs and risk of haemorrhagic complications compared to the general population. Identification of haemostatic disorders is crucial for implementing preventive measures and mitigating bleeding risk. This review aims to provide a comprehensive overview of genetic syndromes that predispose children to bleeding due to haemostatic dysfunction.
methodsGenetic syndromes associated with bleeding diathesis related to haemostatic disorders were identified using the Human Phenotype Ontology. A comprehensive literature review was conducted to summarise the clinical and laboratory findings, as well as the types of haemostatic abnormalities associated with each genetic syndrome.
resultsEighteen genetic diseases were included, with platelet dysfunction the most common cause of haemorrhagic syndrome in 17 of them. A coagulation factor deficiency has been described in four diseases. Six diseases expose patients to a risk of severe bleeding. For each genetic disorder, we detailed the mechanism of haemostasis dysfunction and the haemostasis abnormalities that may be observed.
conclusionRecognising haemostatic abnormalities in children with genetic diseases allows for more effective clinical management. Systematic coagulation screening is recommended for all patients with the syndromes discussed in this review.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.